ROZANOLIXIZUMAB

UNII: P7186074QC
Preferred Substance Name: ROZANOLIXIZUMAB

1584645-37-3
IMMUNOGLOBULIN G4, ANTI-(HUMAN FCRN RECEPTOR) (HUMAN-RATTUS NORVEGICUS MONOCLONAL UCB 7665 HEAVY CHAIN), DISULFIDE WITH HUMAN-RATTUS NORVEGICUS MONOCLONAL UCB 7665 LIGHT CHAIN, DIMER
ROZANOLIXIZUMAB [INN]
ROZANOLIXIZUMAB [JAN]
ROZANOLIXIZUMAB [USAN]
ROZANOLIXIZUMAB [WHO-DD]
ROZANOLIXIZUMAB-NOLI
RYSTIGGO
UCB7665
UCB-7665

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

ROZANOLIXIZUMAB

Synonyms and Mappings

Resources

Note